IP Library Granted Patent US 7,045,342
Granted Patent B2
US 7,045,342 · App. 10/794,516 · Granted May 16, 2006

Diagnostic detection device and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,045,342
App. No.
10/794,516
Granted
May 16, 2006
Kind
B2
Abstract

The invention provides an improved test cell for detecting the presence of an analyte in a liquid sample. The device has an elongate casing defining a liquid sample inlet, a reservoir volume, a test volume, and a window through the casing at the test volume. Disposed within the cell is a sample absorbent, a novel biphasic substrate and a reservoir, together capable of transporting an aqueous solution within the casing along a flow path extending from the sample inlet through the test volume and into the reservoir volume. The invention further comprises a method for detecting the presence of an analyte in a liquid sample using the device and a biphasic chromatographic material for carrying out the method.

Claims (31)

1. A device for determining the presence in a liquid sample of an analyte wherein liquid sample deposited on a proximal end of the device travels downstream along a liquid path to a distal end of the device, the device comprising:

a biphasic substrate comprising (1) a release medium of a first material and, in fluid communication and downstream thereof, (2) a capture medium of a microporous, second, different material,

wherein located at the release medium of the biphasic substrate for release therefrom is

(i) a labeled conjugate comprising a binding member reactive with a first epitope of the analyte labeled with a detectable marker, and

(ii) a capturable component reactive with a second epitope of the analyte, such that if the analyte is present in the sample, the analyte produces a complex comprising the labeled conjugate, the analyte and the capturable component, and

located at the capture medium of the biphasic substrate is

a capture site for capturing the complex, the capture site having immobilized thereon a capture component having a binding affinity for the capturable component.

2. The device of claim 1 further comprising a control site located downstream of the capture site, the control site having immobilized thereon an agent having a binding affinity for the labeled conjugate.

3. The device of claim 1 wherein the capture medium is laminated to or cast on a transparent polymeric material.

4. The device of claim 1 comprising a sample absorbent located upstream of the biphasic substrate at the proximal end of the device.

5. The device of claim 1 further comprising a residual absorbent located downstream of the biphasic substrate at the distal end of the device.

6. The device of claim 1 wherein the binding member of the labeled conjugate is an antibody.

7. The device of claim 1 wherein the capturable component is a biotinylated antibody.

8. The device of claim 7 wherein the immobilized capture component comprises avidin, streptavidin or an antibiotin antibody.

9. The device of claim 1 wherein the immobilized capture component comprises avidin, streptavidin, or an antibiotin antibody.

10. The device of claim 1 wherein the second material of the biphasic substrate is nitrocellulose or nylon.

11. The device of claim 1 wherein the first material of the biphasic substrate is absorbent paper.

12. The device of claim 1 wherein the release medium and the capture medium of the biphasic substrate are both immobilized on a single backing support.

13. A device for determining the presence in a liquid sample of an analyte wherein liquid sample deposited on a proximal end of the device travels downstream along a liquid path to a distal end of the device, the device comprising:

a biphasic substrate comprising (1) a release medium of a first material and in fluid communication and downstream thereof, (2) a capture medium of a second, different material of nylon or nitrocellulose, wherein the release medium and the capture medium are both immobilized on a single backing support,

wherein located at the release medium of the biphasic substrate for release therefrom is

(i) a labeled conjugate comprising a first antibody that binds a first epitope of the analyte labeled with a detectable marker, and

(ii) a capturable component comprising a biotinylated second antibody that binds a second, different epitope of the analyte, such that if the analyte is present in the sample, the analyte produces a complex comprising the labeled conjugate, the analyte and the capturable component, and

located at the capture medium of the biphasic substrate is

a capture site for capturing the complex, the capture site having a capture component immobilized thereon for biding the capturable component.

14. The device of claim 13 further comprising a control site located downstream of the capture site, the control site having immobilized thereon an agent having binding affinity for the labeled conjugate.

15. The device of claim 13 , wherein the capture medium is laminated to or cast on a transparent polymeric material.

16. The device of claim 13 further comprising a sample absorbent located upstream of the biphasic substrate at the proximal end of the device.

17. The device of claim 13 further comprising a residual absorbent located downstream of the biphasic substrate at the distal end of the device.

18. The device of claim 13 , wherein the first material of the biphasic substrate is absorbent paper.

19. The device of claim 13 , wherein the capture component is avidin or streptavidin.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Nov 23, 2010
From: JP MORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
To: CHURCH & DWIGHT CO., INC.
Reel/Frame 025412/0892 →
SECURITY AGREEMENT Recorded Apr 24, 2007
From: CHURCH & DWIGHT CO., INC.
To: JPMORGAN CHASE BANK, N.A. (FORMERLY KNOWN AS THE CHASE MANHATTAN BANK), AS ADMINISTRATIVE AGENT
Reel/Frame 019193/0966 →
MERGER Recorded Aug 3, 2004
From: ARMKEL LLC
To: CHURCH & DWIGHT CO., INC.
Reel/Frame 014934/0603 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2004
From: MEDPOINTE HEALTHCARE, INC.
To: ARMKEL, LLC
Reel/Frame 015212/0450 →
CHANGE OF NAME Recorded Apr 15, 2004
From: CARTER WALLACE, INC.
To: MEDPOINTE HEALTHCARE, INC.
Reel/Frame 015214/0093 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2004
From: NAZARETH, ALBERT; BOYLE, MARY BETH; CHENG, YEA-SHUN
To: CARTER WALLACE, INC.
Reel/Frame 015214/0103 →